These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9574699)

  • 1. Comparative evaluation of National Committee for Clinical Laboratory Standards broth macrodilution and agar dilution screening methods for testing fluconazole susceptibility of Cryptococcus neoformans.
    Kirkpatrick WR; McAtee RK; Revankar SG; Fothergill AW; McCarthy DI; Rinaldi MG; Patterson TF
    J Clin Microbiol; 1998 May; 36(5):1330-2. PubMed ID: 9574699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans.
    Patterson TF; Kirkpatrick WR; Revankar SG; McAtee RK; Fothergill AW; McCarthy DI; Rinaldi MG
    J Clin Microbiol; 1996 Dec; 34(12):3237-9. PubMed ID: 8940483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of broth macrodilution, broth microdilution and E-test susceptibility tests of Cryptococcus neoformans for fluconazole.
    Chryssanthou E; Grönfors C; Khanna N
    Mycoses; 1997 Dec; 40(11-12):423-7. PubMed ID: 9470407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique.
    Chen SC; O'Donnell ML; Gordon S; Gilbert GL
    J Antimicrob Chemother; 1996 Feb; 37(2):265-73. PubMed ID: 8707736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the NCCLS M44-P disk diffusion method for determining susceptibilities of 276 clinical isolates of Cryptococcus neoformans to fluconazole.
    Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Diekema DJ
    J Clin Microbiol; 2004 Jan; 42(1):380-3. PubMed ID: 14715784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
    To WK; Fothergill AW; Rinaldi MG
    J Clin Microbiol; 1995 Oct; 33(10):2660-4. PubMed ID: 8567901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goiânia city, Goiás, Brazil.
    Souza LK; Fernandes Ode F; Kobayashi CC; Passos XS; Costa CR; Lemos JA; Souza-Júnior AH; Silva Mdo R
    Rev Inst Med Trop Sao Paulo; 2005; 47(5):253-6. PubMed ID: 16302107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans.
    Krishnarao TV; Galgiani JN
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1957-60. PubMed ID: 9303393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard.
    Barchiesi F; Colombo AL; McGough DA; Rinaldi MG
    J Clin Microbiol; 1994 Oct; 32(10):2494-500. PubMed ID: 7814488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluconazole and amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E-test and semiautomated broth microdilution test.
    van Eldere J; Joosten L; Verhaeghe V; Surmont I
    J Clin Microbiol; 1996 Apr; 34(4):842-7. PubMed ID: 8815094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients.
    Jessup CJ; Pfaller MA; Messer SA; Zhang J; Tumberland M; Mbidde EK; Ghannoum MA
    J Clin Microbiol; 1998 Oct; 36(10):2874-6. PubMed ID: 9738036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts.
    Arthington-Skaggs BA; Motley M; Warnock DW; Morrison CJ
    J Clin Microbiol; 2000 Jun; 38(6):2254-60. PubMed ID: 10834985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests.
    Espinel-Ingroff A; Kerkering TM; Goldson PR; Shadomy S
    J Clin Microbiol; 1991 Jun; 29(6):1089-94. PubMed ID: 1864923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter evaluation of broth microdilution method for susceptibility testing of Cryptococcus neoformans against fluconazole.
    Sanati H; Messer SA; Pfaller M; Witt M; Larsen R; Espinel-Ingroff A; Ghannoum M
    J Clin Microbiol; 1996 May; 34(5):1280-2. PubMed ID: 8727919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents.
    Aller AI; Martín-Mazuelos E; Gutiérrez MJ; Bernal S; Chávez M; Recio FJ
    J Antimicrob Chemother; 2000 Dec; 46(6):997-1000. PubMed ID: 11102421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of fluconazole MICs with clinical outcome in cryptococcal infection.
    Aller AI; Martin-Mazuelos E; Lozano F; Gomez-Mateos J; Steele-Moore L; Holloway WJ; Gutiérrez MJ; Recio FJ; Espinel-Ingroff A
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1544-8. PubMed ID: 10817706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2862-4. PubMed ID: 11557481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility testing of Cryptococcus neoformans: a microdilution technique.
    Ghannoum MA; Ibrahim AS; Fu Y; Shafiq MC; Edwards JE; Criddle RS
    J Clin Microbiol; 1992 Nov; 30(11):2881-6. PubMed ID: 1452658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal susceptibility of Cryptococcus neoformans isolates in HIV-infected patients to fluconazole, itraconazole and voriconazole in Spain: 1994-1996 and 1997-2005.
    Aller AI; Claro R; Castro C; Serrano C; Colom MF; Martín-Mazuelos E
    Chemotherapy; 2007; 53(4):300-5. PubMed ID: 17496416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing.
    Colombo AL; Barchiesi F; McGough DA; Rinaldi MG
    J Clin Microbiol; 1995 Mar; 33(3):535-40. PubMed ID: 7751353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.